CPT 0521U Seronegative RA Panel Reimbursement

CPT code 0521U designates a Proprietary Laboratory Analyses (PLA) test: the Seronegative Rheumatoid Arthritis Panel from KSL Diagnostics–Beutner Laboratories Inc. and KSL Biomedical Inc. The panel measures rheumatoid factor IgA and IgM, cyclic citrullinated peptide (CCP) antibodies, and scavenger receptor A (SR–A) via immunoassay, supporting diagnosis and evaluation of patients with suspected seronegative rheumatoid arthritis. As a PLA code, 0521U is specific to a single manufacturer’s assay and is used when that exact test is performed.

This publication addresses national implications for clinicians, laboratorians, and payers. Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the analytes included in the panel, typical settings where the service is performed, and an overview of reimbursement and coverage topics relevant to proprietary laboratory tests. The report summarizes benchmarks and payer coverage patterns where available, highlights policy considerations around PLA codes, and explains how 0521U fits within laboratory service line billing. Data not available in the input are noted where applicable.

Billing Code Overview

CPT code 0521U is a Proprietary Laboratory Analyses (PLA) code that applies to a single laboratory test: the Seronegative Rheumatoid Arthritis Panel offered by KSL Diagnostics–Beutner Laboratories Inc. and KSL Biomedical Inc. The test assesses serologic markers used in rheumatoid arthritis evaluation, measuring rheumatoid factor IgA and IgM, cyclic citrullinated peptide (CCP) antibodies, and scavenger receptor A (SR–A) using immunoassay technology.

Service Type: Laboratory immunoassay panel for rheumatoid arthritis serology

Typical Site of Service: Clinical laboratory or reference laboratory; specimen collection may occur in outpatient clinics or physician offices

Clinical Context

A 47-year-old patient presents to a rheumatology clinic with a 6-month history of persistent symmetric polyarthralgia, morning stiffness lasting more than one hour, intermittent swelling of small hand joints, and negative standard serologic tests for rheumatoid arthritis (negative rheumatoid factor IgM on routine testing and negative anti-CCP by prior lab). The clinician suspects seronegative rheumatoid arthritis given clinical exam and imaging showing early erosive changes on hand radiographs. The rheumatologist orders the proprietary Seronegative Rheumatoid Arthritis Panel (0521U) from KSL Diagnostics–Beutner Laboratories Inc. to measure rheumatoid factor IgA and IgM, cyclic citrullinated peptide (CCP) antibodies, and scavenger receptor A (SR–A) using immunoassay technology.

Specimen collection, labeling, and transport follow outpatient phlebotomy protocols; the laboratory performs the proprietary immunoassays, reports quantitative and qualitative results, and sends a report to the ordering provider. Results are used to support or refine the diagnosis, guide discussions about initiation of disease-modifying antirheumatic drug therapy, and document objective serologic findings in the patient record. Typical site of service for ordering and specimen collection is an outpatient clinic, ambulatory infusion center, or independent phlebotomy draw station; testing is performed at the manufacturer-specific clinical laboratory that developed the PLA test.

Coding Specifications

Modifier	Description	When to Use
`00`

Taxonomy Code	Specialty	Notes
207RH0000X	Rheumatology	Specialists ordering serologic panels for inflammatory arthritis diagnosis.
208D00000X	Diagnostic Laboratory	Clinical laboratory performing proprietary immunoassays and reporting results.
2080P0005X	Pathology & Laboratory Medicine	Laboratory medicine specialists overseeing assay validation and interpretation standards.
207LP2900X	Internal Medicine	Primary care or general internists who may order the panel during diagnostic workup of inflammatory arthritis.
207RI0001X	Pediatric Rheumatology	Pediatric rheumatologists ordering serologic testing for juvenile idiopathic arthritis cases with seronegative features.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`M06.0`	Rheumatoid arthritis with rheumatoid factor	Differential diagnosis; serologic testing helps distinguish seropositive vs seronegative disease.
`M06.9`	Rheumatoid arthritis, unspecified	Common diagnostic label during initial evaluation when serology is pending or inconclusive.
`M06.8`	Other rheumatoid arthritis with rheumatoid factor	Used for variant RA presentations; serologic panel can clarify antibody status.
`M12.0`	Seronegative spondyloarthritis	Differential consideration for seronegative inflammatory arthritides; testing may help exclude RA.
`R68.89`	Other general symptoms and signs; includes constitutional symptoms	Symptoms such as fatigue and malaise often accompany inflammatory arthritis and prompt broader testing.
`M79.0`	Rheumatism, unspecified and other soft tissue disorders, not elsewhere classified	Symptom-driven testing when joint pain is present but specific diagnosis pending.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80054`	Chemistry panel; comprehensive metabolic panel	Often ordered concurrently to assess baseline organ function before initiating disease-modifying therapy guided by serologic results.
`86318`	Immunoassay for infectious agent antibody, quantitative (example code for immunoassays)	Represents the general class of immunoassay methodology; `0521U` is a PLA specific to a manufacturer using immunoassay technology.
`86431`	Antibody; rheumatoid factor, quantitation	Standard rheumatoid factor quantitative testing that may be ordered alongside or prior to the proprietary seronegative panel for comparison.
`86255`	Antibody; cyclic citrullinated peptide (CCP), qualitative or semi-quantitative	Common anti-CCP testing; the PLA `0521U` measures CCP antibodies as part of a proprietary panel.
`99000`	Handling and/or conveyance of specimen for transfer from physician to laboratory (This is an example non-billable code — use payer guidelines)	Relates to specimen handling and transport logistics when specimens are sent to the specialized laboratory performing the PLA test.

OpenPayer

Summary & Overview

CPT 0521U: Seronegative Rheumatoid Arthritis Panel